Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.radonc.2011.12.028
Title: | Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma | Authors: | Tuan, J.K.L. Ha, T.C. Ong, W.S. Siow, T.R. Tham, I.W.K. Yap, S.P. Tan, T.W.K. Chua, E.T. Fong, K.W. Wee, J.T.S. |
Keywords: | Conventional radiation Cranial nerve palsies Late treatment toxicity Nasopharyngeal cancer Quality of life |
Issue Date: | Sep-2012 | Citation: | Tuan, J.K.L., Ha, T.C., Ong, W.S., Siow, T.R., Tham, I.W.K., Yap, S.P., Tan, T.W.K., Chua, E.T., Fong, K.W., Wee, J.T.S. (2012-09). Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma. Radiotherapy and Oncology 104 (3) : 305-311. ScholarBank@NUS Repository. https://doi.org/10.1016/j.radonc.2011.12.028 | Abstract: | Background and purpose: We sought to evaluate the nature and frequency of late toxicities in a cohort of nasopharyngeal cancer (NPC) patients treated with conventional radiotherapy alone. Methods and materials: Seven-hundred and ninety-six consecutive NPC patients treated using conventional radiotherapy at a single center from 1992 to 1995 were retrospectively analyzed. Patients with histology proven, completely staged, Stage I-IVB World Health Organization Type I-III NPC and completed radical radiotherapy were included. Patients with incomplete staging investigations, distant metastases at diagnosis, previous treatment, and incomplete radiotherapy were excluded. Radiotherapy-related complications were categorized using the RTOG Late Radiation Morbidity Scoring Criteria. Results: Median follow-up was 7.2 years. The 5-year overall survival and disease free survival were 69% and 56%, respectively, and the corresponding 10-year rates were 52% and 44%. Among 771 patients with at least 3 months of follow-up post treatment, 565 (73%) developed RT-related complications. Diagnosed neurological complications were cranial nerve palsies (n = 70; 9%), temporal lobe necrosis (n = 37; 5%), Lhermitte's syndrome (n = 7; 1%), and brachial plexopathy (n = 2; 0.3%). Non-neurological complications included xerostomia (n = 353; 46%), neck fibrosis (n = 169; 22%), hypo-pituitarism (n = 48; 6%), hearing loss (n = 120; 16%), dysphagia (n = 116; 15%), otorrhea (n = 101; 13%), tinnitus (n = 94; 12%), permanent tube feeding (n = 61; 8%), trismus (n = 45; 6%), second malignancies within treatment field (n = 17; 2%), and osteo-radionecrosis (n = 13; 2%). Conclusions: While radiotherapy is curative in NPC, many patients suffer significant late treatment morbidities with conventional radiotherapy techniques. © 2012 Elsevier Ireland Ltd. All rights reserved. | Source Title: | Radiotherapy and Oncology | URI: | http://scholarbank.nus.edu.sg/handle/10635/124890 | ISSN: | 01678140 | DOI: | 10.1016/j.radonc.2011.12.028 |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
SCOPUSTM
Citations
56
checked on Feb 25, 2021
WEB OF SCIENCETM
Citations
48
checked on Feb 25, 2021
Page view(s)
75
checked on Feb 13, 2021
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.